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ABSTRACT 
COMPUTER SIMULATION OF CEREBROVASCULAR CIRCULATION. 
ASSESSMENT OF INTRACRANIAL HEMODYNAMICS DURING 
INDUCTION OF ANESTHESIA. 
by 
Steven D. Wolk 
The purpose of this project was to develop a computer model of cerebrovascular 
hemodynamics interacting with a pharmacokinetic drug model to examine the effects of 
various stimuli during anesthesia on cerebral blood flow and intracranial pressure. 
The mathematical model of intracranial hemodynamics is a seven compartment 
constant volume system. A series of resistances relate blood and cerebrospinal fluid 
fluxes to pressure gradients between compartments. Arterial, venous, and tissue 
compliance are also included. Autoregulation is modeled by transmural pressure 
dependent arterial-arteriolar resistance. 	The effect of a drug (thiopental) on 
cerebrovascular circulation was simulated by a variable arteriolar-capillary resistance. 
Thiopental concentration, in turn, was predicted by a three-compartment 
pharmacokinetic model. The effect site compartment was included to account for a 
disequilibrium between drug plasma and biophase concentrations. The model was 
validated by comparing simulation results with available experimental observations. The 
simulation program is written in VisSiM® dynamic simulation language for an IBM-
compatible PC. 
The model developed was used to calculate cerebral blood flow and intracranial 
pressure changes which occur during the induction phase of general anesthesia. 
Responses to laryngoscopy and intubation were predicted for simulated patients with 
elevated intracranial pressure and nonautoregulated cerebral circulation. Simulation 
shows that the induction dose of thiopental reduces intracranial pressure up to 15%. The 
duration of this effect is limited to less than three minutes by rapid redistribution of 
thiopental and cerebral autoregulation. 	Subsequent laryngoscopy causes acute 
intracranial hypertension exceeding the initial intracranial pressure. Further simulation 
predicts that this untoward effect can be minimized by an additional dose of thiopental 
administered immediately prior to intubation. 
The presented simulation allows comparison of various drug administration schedules 
to control intracranial pressure and preserve cerebral blood flow during induction of 
anesthesia. The model developed can be extended to analyze more complex 
intraoperative events by adding new submodels. 
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Quantitative understanding of how hemodynamic changes influence cerebrovascular 
responses in neurosurgical patients is essential to prevent untoward changes in 
intracranial pressure (ICP) and cerebral perfusion pressure (CPP). This information is 
usually obtained from studies in which all variables except the one under investigation 
are controlled. During administration of anesthesia, however, multiple pharmacological 
and mechanical interventions may take place simultaneously. The resultant effect of 
these manipulations on cerebrovascular hemodynamics is difficult to predict despite an 
abundance of detailed information about mechanisms of drug actions. In other words, 
there are large number of analytical investigations but a scarcity of significant synthetic 
studies at present. A computer model of the cerebrovascular circulation combined with a 
pharmacokinetic and pharmacodynamic model of a particular drug is a method which 
potentially allows systematic examination of the whole system. 
The aim of this study is to develop a model of cerebrovascular circulation which 
interfaces with a pharmacokinetic drug model. This objective requires linking of blood 
flow and drug distribution kinetics, and is used in anesthesia simulators and studies of the 
cardiovascular system [1-5]. The model developed can simulate the effects of drug(s) on 
intracranial hemodynamics. The changes in cerebral blood flow (CBF) and 1CP were 
calculated during induction of general anesthesia. 	Hemodynamic responses to 
laryngoscopy and endotracheal intubation were predicted for simulated patients with 
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autoregulated and non-autoregulated cerebral circulations. Because thiopental is a 
widely used and extensively studied induction agent in neuroanesthesia, it was chosen as 
the sole induction agent in our analysis in order to validate the simulation. Computed 
results were then compared to available experimental data. The model was also used to 
suggest a drug administration regimen which minimized intracranial pressure increases 
associated with endotracheal stimulation. 
CHAPTER 2 
MODEL DEVELOPMENT 
The overall simulation program structure is shown in Figure I . The sub-model of the 
cerebrovascular system was constructed using a lumped-parameter method, in which the 
variables (e.g. pressure, flow, etc.) are assumed to be uniform within defined zones or 
control volumes. This approach is widely used in modeling physiological systems [6-9]. 
It enables prediction of average trends and responses of the system when subjected to 
pressure and flow perturbations. 	The other submodel is a three-compartment 
pharmacokinetic model of thiopental transport and metabolism linked to the biophase 
compartment by the first order rate process. Thiopental primarily affects mean systemic 
arterial pressure which secondarily influences CBF and ICP. This is used as an input 
parameter to the cerebrovascular circulation sub-model. Action of the pharmacokinetic 
model on hemodynamic model also occurs through regulation of the drug concentration 
dependent arteriolar-capillary resistance. The model developed does not include the 
effect of hemodynamic perturbations on pharmacokinetic parameters. 
3 
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Figure 1 Overall structure of the model. κ12, κ21, κ13, κ 31 = first-order, inter-compartment 
rate constants; K10=first-order elimination constant; Keo= first-order equilibrium constant 
between central and effect site compartments; Ce = apparent thiopental concentration at the 
effect site; Pa, Par = arterial and arteriolar pressures; Pc, Pv = capillary and cerebral venous 
pressures; Pvs = venous sinus pressure; P, = central venous pressure; Caf, Cvf = cerebral 
arterial and venous compliances; Cr = brain tissue compliance; Cve = extracranial venous 
compliance; Raar = variable arterial-arteriolar resistance (transmural pressure-dependent); Rarc  
= arteriolar-capillary resistance (thiopental concentration dependent); Rev, Rvvs = capillary-
venous system-venous sinuses resistance; Ref, fvs  = resistance to cerebrospinal fluid 
formation and cerebrospinal fluid outflow; Rvsce = resistance to the extracranial venous 
outflow.  
2.1 Intracranial Hemodynamics Model 
During the last decade various biophysical and mathematical models of intracranial 
hemodynamics have been developed [9-15]. Depending on the aim of the study, authors 
focused their attention on a particular aspect of CBF or CSF dynamics. The most 
complete model of cerebral circulation was formulated by Ursino [15,16]. The unique 
aspect of this model is its ability to combine many specific attributes of cerebral 
hemodynamics. In particular it includes CBF autoregulation, simulates CSF formation 
rate as a function of transmural pressure, and calculates model parameters using 
physiological and recent anatomical data. A modified version of this model was used in 
our simulation. Modification of the original model was required to introduce drug 
concentration dependent parameters to predict system behavior in clinical situation. 
The equations and parameters for the intracranial hemodynamics model are presented in 
detail and are justified in the original articles [15,17]. Only general principles and our 
modifications will be discussed in this paper. In its present form the model is a constant 
volume system consisting of seven compartments: cerebrovascular arterial and arteriolar 
beds, intracranial capillary compartment, venous vascular bed, venous sinuses, 
cerebrospinal fluid compartment (brain tissue), and a central venous compartment. The 
behavior of each compartment is represented by a single pressure value and by values of 
mass flux exchanged with adjacent compartments. A series of resistances relate blood 
and CSF fluxes to the pressure gradient between compartments: 
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where Vn is the volume of compartment n surrounded by m compartments, qmn denotes 
the flux between compartments in and n, (Pm - Pn) is the pressure difference between the 
n-th and m-th compartment, and Rmn is the resistance of the compartmental boundary. 
CSF production is directly proportional to capillary transmural pressure and inversely 
proportional to choroid plexus resistance to CSF secretion. CSF re-absorption depends 
on the difference between CSF and dural sinus pressure and is inversely related to 
arachnoid viii resistance to fluid flow. Temporal changes of cerebral arterial and venous 
blood volumes are taken into account with the two lumped parameters, arterial and 
venous compliance. An exponential pressure-volume relationship has been assumed. 
This implies that compliances of these compartments are inversely proportional to the 
corresponding value of distending pressure where Cai and Cvi are arterial and venous 
compliances respectively, Ka and Kv arterial and venous elastance coefficients; values 
for these parameters were computed based on anatomical data on major human 
intracranial vessels. Pa, Pic, Pv are pressures in arterial, intracranial, and venous 
compartments respectively. Pvi denotes the transmural pressure value at which the large 
cerebral veins would collapse. 
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Compliance of cerebral tissue is described by the following equation: 
where Ke is an elastance of cerebral tissue and P1  is a constant. According to this 
equation tissue compliance is fairly linear at low ICP, but decreases dramatically as 
intracranial pressure increases (quadratic term in the equation become relevant). 
Detailed explanations and derivations describing the pressure dependency of arterial, 
venous, and cerebral tissue compartments are presented elsewhere [15]. 
Differential equations describing intracranial dynamics can be written by imposing a 
mass balance for each compartment. Compact form of these equations for all cells is: 
where Cmn(Pm, Pn) is the pressure dependent compliance of the nth compartment. 
The constancy of intracranial volume (Monro-Kelly principle) is expressed by the 
following equation: 
where Q denotes rate at which the CSF compartment can expand. This can be used to 
simulate the injection of liquid into the CSF space ( used clinically to test intracranial 
compliance in neurosurgical practice) as well as certain pathologic conditions (e.g. 
subarachnoid hemorrhage). 
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Cerebral autoregulation is represented by a transmural pressure dependent arterial- 
arteriolar cerebrovascular conductance. 	In the original model, an S-shaped 
autoregulatory curve was assumed and simulated using characteristics of the arctangent 
function. The regulatory mechanism gain is an argument in the equation. The gain, in 
turn, was determined by solution of a first order differential equation which includes a 
time constant and a perfusion pressure percent change. This allows study of the partially 
autoregulated circulation by changing equation parameters. Although satisfactory for 
theoretical analysis of cerebrovascular physiology, the resulting autoregulatory curve 
correlates poorly with the well described cerebral blood flow vs arterial pressure 
relationship based on experimental measurements in humans reported in numerous 
publications [18-20]. The data from [20] were used in our model to develop a table 
function of arterial-arteriolar conductances (inverse of resistance) vs transmural pressures 
across arterial wall. Figure 2 shows calculated conductances that were used in the 
present model. The shape of the curve is consistent with experimentally observed 
changes in autoregulatory resistance [19]. During the computational cycle the program 
chooses a conductance corresponding to the transmural pressure value at any given time. 
A six second time delay following a step change in arterial blood pressure was 
introduced to reflect the dynamic nature of the autoregulatory response, as was 
experimentally determined by Aaslid, et al.[21]. 
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Figure 2 Variations of arterial -arteriolar conductance (Ga-ar) with blood pressure;   is 
calculated from cerebral blood flow versus mean arterial pressure data reported by Harper 
and McCulloch [20] 
Figure 3 compares autoregulatory curves generated by the original model, by our 
modification, and experimental points from several studies reported by Lassen [18]. 
A table function describes only one autoregulatory curve. It lacks the flexibility of 
differential equation in constructing a series of partially autoregulated curves offered by 
the original model. Our choice of a table function was dictated by poor correlation of the 
equation generated curve with experimental data and an inability to find an experimental 
verification of partial autoregulation. The absence of autoregulation in our model was  
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studied by assuming fixed arterial-arteriolar conductance (conductance at mean arterial 
pressure of 100 mmHg) at all pressures. 
Figure 3 Autoregulatory curves predicted by the present model and calculated using 
solution of differential equations as described by Ursino [15]. Experimental points are from 
Lassen [18]. Mean values of 9 groups of subjects have been plotted. 
The effect of thiopental on cerebrovascular circulation was simulated by a 
concentration dependent arteriolar-capillary resistance. Postulating that this resistance is 
the only site of thiopental action in the brain, the model can be used to develop a 
conductance (reverse of resistance) versus concentration function from experimental data 
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relating thiopental concentration and CBF [22]. Calculated conductance values were 
regressed using exponential equation: 
where x is thiopental concentration in ptg/mL. Product moment correlation coefficient 
for this equation, r, equals 0.95. 
Following a bolus intravenous injection, thiopental decreases systemic arterial 
pressure by reducing cardiac output and by venodilation [23]. Experimental data from 
several investigations studying the cardiovascular effects of thiopental during induction 
of anesthesia, were regressed to develop a relationship between thiopental concentration 
and mean systemic arterial pressure: 
where x is thiopental concentration in µg/mL and MAP is mean arterial pressure in 
mmHg. There is good correlation between experimental data and the above equation (r = 
0.96). 
2.2 Pharmacokinetic Model 
The three compartment model was used to calculate plasma concentration of thiopental at 
various times. Pharmacokinetic parameters reported by Stanski et al. [25] were used in 
our simulation. Plasma concentration was linked to the apparent effect-site concentration 
with a first-order rate constant, Ke0. Effect-compartment was introduced to account for 
temporal dissociation between serum (central compartment), thiopental concentration and 
EEG effect. Numeric integration of the system of three linear differential equations can 
predict plasma concentration of thiopental following bolus injection. However, the 
simulation language structure used to solve the model equations (VisSim®) does not 
permit interruption of the numerical integration when the additional drug boluses are 
studied. To simulate a clinical setting when two or more injections are required, an 
analytical solution of the system of three linear differential equations proposed by Hull et 
al. [26] was used in our model. The solution allows simulation of multiple injections as 
well as the continuous infusion of drug [27]. 
2.3 Operation of the Computer Model 
The simulation program was written in VisSim®, a simulation programming language for 
an IBM compatible PC. In VisSim®, models are constructed in the form of block 
diagrams. Each interconnected block represents and describes a portion of the system. 
The specifics of programming using block diagram languages are discussed by 
Karayanakis [28]. Fourth-order Runge-Kutta integration blocks with a time interval of 
50 msec were chosen for a solution of the model equations. A 32-bit PC microcomputer 
was used to realize real-time simulation. 
CHAPTER 3 
RESULTS 
Simulation results include computation of cerebral blood flow as a function of mean 
arterial pressure at different intracranial pressures and prediction of cerebrovascular 
responses during the induction phase of general anesthesia. Changes in cerebral blood 
flow and intracranial pressure are calculated for simulated patients with and without 
autoregulation. The predictions of the model are compared with available experimental 
data. 
Figure 4 Cerebral blood flow as a function of cerebral perfusion pressure and intracranial 
pressure (10, 30 and 50 mmHg); it is assumed that autoregulation is intact at all times. 
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3.1 Effect of ICP on CBF 
Figure 4 compares CBF calculated for MAP up to 170 mmHg for simulated patients with 
ICP of 10, 30, and 50 mmHg. The model predicts that an ICP increase shifts the 
autoregulatory curve to the right. A higher cerebral perfusion pressure is required to 
maintain cerebral blood flow in these patients. ICP elevation was accomplished by 
increasing resistance to CSF re-absorption. The original model used liquid bolus injected 
into the CSF space to simulate intracranial hypertension. This results in a transient 
response and could not be used for our simulation. 
Autoregulation is modified or impaired in areas surrounding a space occupying, 
traumatic, or inflammatory lesion and may be completely lost in severe head injury 
[18,29]. Loss of autoregulation may leave surviving brain tissue unprotected against the 
potentially deleterious effects of significant blood pressure changes. Figure 5 shows that 
absence of autoregulation results in a passive CBF increase if systemic blood pressure is 
increased. Sengupta et al. [30] demonstrated a similar relationship between MAP and 
CBF in primates with compromised cerebral circulation. Intracranial hypertension 
reduces transmural pressure and increases vascular resistance. This is reflected in a 
decreased slope of CBF versus ICP with the elevation of ICP. 
3.2 Clinical Applications 
The induction of general anesthesia was modeled using a bolus thiopental injection 
followed by laryngoscopy and incubation. ICP and CBF changes were compared for 
cerebral circulation with intact and compromised autoregulation. Simulation is initiated 
by injecting a typical induction dose of thiopental (5 mg/kg). It is assumed that a 
15 
hemodynamically stable nondepolarizing neuromuscular agent is administered essentially 
at the same time (e.g. vecuronium). Under normal conditions hemodynamically stable 
relaxants do not alter CBF or 1CP and their influence on intracranial hemodynamics is 
expressed primarily by determining a time for laryngoscopy and intubation 
(approximately two minutes). 
Figure 5 Cerebral blood flow as a function of cerebral perfusion pressure in non-
autoregulated cerebral circulation. 
Laryngoscopy and tracheal intubation are associated with sympathetic discharge 
which may lead to a hypertensive response [31,32]. If thiopental is used as the sole 
induction agent, endotracheal stimulation may increase MAP by 35 ± 10 mmHg 
16 
compared to preinduction values and by 60 ± 20 mmHg compared to preintubation 
values [33,34]. In our model, systemic hypertension was simulated by adding 60 mmHg 
to the value of MAP 120 seconds following the induction dose of thiopental, Stimulation 
persisted for 30 seconds. 
Figure 6 Changes in intracranial pressure during induction of anesthesia in a simulated 
patient with intact autoregulation; A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy 
begins. 
ICP and CBF changes during induction of anesthesia were computed for initial ICP 
values of 10, 30 and 50 mmHg. Figure 6 shows that an induction dose of thiopental 
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decreases ICP. The model predicts that ICP reduction is more pronounced in patients 
with increased intracranial pressure (7% for patients with ICP of 10 mmHg and 15% for 
patients with ICP of 50 mmHg). This effect, however, lasts less than three minutes. 
Autoregulation and rapid redistribution of thiopental resulting in systemic pressure rise 
lead to ICP elevation almost to preinduction level. Subsequent laryngeal stimulation 
raises ICP by 5 mmHg. 
Figure 7 Changes in intracranial pressure during induction of anesthesia in simulated 
patient without autoregulation: A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy 
begins. 
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Figure 7 shows simulated ICP changes after a thiopental bolus and endotracheal 
intubation in a patient without autoregulation. 	Simulation demonstrates that 
laryngoscopy and endotracheal intubation may dangerously increase ICP by an additional 
14 and 26 mmHg in compromised patients whose intracranial pressure begins at 30 and 
50 mmHg, respectively. The duration of ICP increase is deteiniined by the length of 
laryngeal stimulation (30 seconds in our simulation). 
Figure 8 Changes in cerebral blood flow during induction of anesthesia in a simulated 
patient with intact autoregulation: A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy 
begins. 
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Figure 9 Changes in cerebral blood flow during induction of anesthesia in a simulated 
patient without autoregulation; A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy 
begins. 
Figures 8 and 9 show simulated CBF changes during induction of general anesthesia 
with thiopental for patients with and without cerebral autoregulation. Similar to 1CP 




The mathematical model described in this paper is being developed to simulate clinical 
behavior of the cerebrovascular circulation. The model is constructed by connecting sub-
models of intracranial hemodynamics and drug pharmacokinetics. The complexity of the 
model can be reduced by using a multiple modeling technique. Simplification is 
achieved by setting up and testing individual units separately and then combining them 
into a complete model [35,36]. The modular approach also allows addition of new units 
to the model as needed. The multiple modeling technique is used to study performance 
of systems with two or more kinds of transport (e.g. momentum, mass, etc.) taking place 
simultaneously [2,3,5,37]. 
In building a model a compromise must be made between model simplicity and 
accuracy of results. Approximations and assumptions are always involved. This model 
was developed to study the effect of phaimacologic and mechanical intervention on the 
cerebrovascular circulation during administration of anesthesia. 	Three sets of 
assumptions were used: assumptions related to development of the intracranial 
hemodynamic model, assumptions related to pharmacokinetics of thiopental, and 
assumptions concerning the simulated example - induction of anesthesia with thiopental. 
Limitations related to these assumptions should be evaluated in order to appreciate the 
results of the simulation. 
20 
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4.1 Circulation Model Limitations 
The lumped parameter model of cerebral circulation was constructed by grouping 
cerebral vessels and brain parenchyma into distinct functional compartments. The 
equations that ensue are linear ordinary differential equations (as opposed to partial 
differential equations for distributed systems). This method does not allow evaluation of 
the relative role of different cerebral regions in regulation of blood flow. Consequently 
pathologic conditions which are associated with regional CBF differences (cerebral 
ischemia, steal phenomena, etc.) can not be studied with this model in its present form. 
Including the arteriolar compartment and thiopental dependent resistance was 
necessary to study the effects of drug concentration on intracranial hemodynamics. A 
dose-dependent reduction of metabolism (CMRO2) with thiopental administration in 
humans and animal experiments is well documented [20,38,39]. Functional depression 
of brain activity leads to a corresponding CBF decrease. Although the exact mechanism 
linking flow and metabolism is unclear, it appears that coupling occurs at the level of 
small arterioles [40]. Thus, arteriolar-capillary resistance was chosen as the model site of 
thiopental action. 
The goal of any particular study deteimines the degree of simplification necessary. 
Metabolic and respiratory factors have been omitted, although they can be added in 
modules as needed. The level Of CO2, H', and 02 profoundly affect CBF and ICP, but it 
was assumed that these parameters were unchanged in order to compare the effects of 
thiopental administration and intubation under various simulated clinical situations. 
Simple "experimental" design was necessary at the initial stage of model development to 
validate simulated results with the available clinical observations. 
22 
Our model includes intracranial arterial, venous, and tissue compliances. Pressure 
difference between adjacent compartments and elastance coefficients determines their 
numerical values. Although it is very likely that elastance coefficients would be affected 
by thiopental concentration, there is no experimental verification of this relationship. 
Thus, only the effect of pressure changes on compliance is included in the model. 
1CP elevation in our simulation was accomplished by increasing a resistance to CSF 
re-absorption. Intracranial hypertension can be produced also by increasing the brain 
tissue elastance coefficient. Comparison of the various ways of decreasing intracranial 
compliance and examination of compliance changes on cerebral blood flow and 
intracranial pressure was not part of this study, but will be addressed in the future. 
4.2 Limitations of Pharmacokinetic Model 
Rigorous determination of thiopental uptake by brain tissue requires knowledge of 
cerebral blood flow, volume, and blood-tissue partition and diffusion coefficients 
(assuming uniform thiopental concentration in various brain regions). To construct a 
complete physiological model of drug distribution this information should be also 
available for other organs. Perfusion-limited models of thiopental disposition have been 
developed by Price [41] and Saidman and Eger [42]. 	Although valuable in 
understanding the general principles of thiopental distribution, these models never gained 
widespread acceptance because of their complexity, arbitrary selection of organ volumes 
and flows, and inherent inability to determine partition and diffusion coefficients in 
humans. 
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An alternative analysis of drug disposition consists of formulating a model containing 
the minimum number of compartments that adequately fit the observed data. Although 
compartmental analysis gives little insight into the physiological determinants of 
phaimacokinetics, these models are widely used in clinical pharmacology and 
anesthesiology due to their simplicity and easy experimental verification. A three 
compartmental model (e.g. tri-exponential equation) is commonly used to describe the 
thiopental concentration-time curve during the first 30 minutes following an intravenous 
bolus administration [23,43] and was used in our simulation. The degree of 
disequilibrium in drug concentration versus time and effect versus time was evaluated by 
adding an effect compartment (biophase) to the three-compartmental model [44]. The 
apparent drug concentration at the effect site was calculated using first order kinetics and 
plasma concentration predicted by the three-compartmental model. The rate constant of 
blood-brain equilibration used in our simulation (k=0.58 mind) was estimated by Stanski 
and Maitre [25] from EEG versus thiopental plasma concentration data. We assumed 
that cardiovascular and central nervous system effects are kinetically indistinguishable. 
Limitations of compartmental analysis in describing early distribution of thiopental 
are well recognized [45]. Compartmental kinetics assumes instantaneous mixing of a 
drug in the central compartment following intravenous injection. Speed of injection, 
however, may influence the drug dose-concentration-effect relationship. Following 
intravenous drug administration, the injected bolus travels along the venous vasculature 
to the right heart. Using a sheep model, Upton and Huang [461 determined that the 
maximum concentration of indocyine green injected into the inferior vena cava occurred 
7 to 18 seconds after injection ( injection time 1 to 10 seconds). Although it is possible 
to study this delay by introducing an additional central compartment [47], it is unlikely 
that a delay of this magnitude will significantly alter model predictions. 
There are several other factors that influence thiopental kinetics, which have not as 
yet been studied. The effects of disease states, can be simulated by changing inter-
compartmental and elimination kinetic constants, but were not evaluated. Thiopental 
protein-binding and the extent of thiopental ionization are not included in this model. 
Thiopental pharmacokinetics determines hemodynamic changes in our model. The 
effects of altered hemodynamic parameters on drug distribution cannot be accounted for 
by the model in its present form. "Closing the loop" will be an important feature of 
future studies. 
4.3 Concerning Simulation 
Laryngoscopy and endotracheal intubation may elevate systemic pressure and ICP [48, 
49]. Although this transient increase is probably unimportant in patients with intact 
autoregulation, brain edema and trans-compartmental brain tissue shifts may occur in 
patients with already compromised intracranial hemodynamic [50,51]. Our computations 
show that a single bolus of thiopental is insufficient to prevent an ICP elevation 
associated with 	intubation carried out 3 min after thiopental administration. 
Cerebrovascular effects of thiopental may be attributed to two basic mechanisms; direct 
arteriolar vasoconstriction and reduction of systemic mean arterial pressure [52]. Both 
effects are dose-dependent. Rapid redistribution of thiopental decreases its plasma 
concentration from 65 ug/mL to 20 ug/mL in 2 minutes. Consequently, systemic arterial 
pressure and cerebrovascular conductance rise, negating the initial desirable action of this 
drug. If cerebral autoregulation is absent, exaggerated elevation of ICP occurs during 
laryngeal stimulation. 
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The pattern of ICP and CBF changes produced by our simulation closely resembles 
experimental in vivo observations. Shapiro et al. [53] and Greenbaum et al. [54] 
demonstrated that patients with preoperative signs of elevated ICP had a significant ICP 
increase (30 to 80 mmHg) during intubation using thiopental. Transcranial Doppler 
ultrasonography of middle cerebral artery blood flow velocity suggests that hypertensive 
responses during laryngoscopy and intubation increase CBF [55,56]. Due to variations in 
experimental conditions, the simulated and experimental results can only be compared 
qualitatively. 
Prevention of hypertensive responses in neurosurgical patients is the subject of 
numerous investigations [57-59]. Our computer model looked at the effect of a second 
dose of thiopental (4.0 mg/kg) prior to intubation. The simulation shows that this will 
attenuate increased ICP and CBF in simulated patients with non-autoregulated cerebral 
circulation (Figures 10 and 11). The additional dose of thiopental reduces MAP and 
extends the time period of cerebral vasoconstriction. 
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Figure 10 Changes in intracranial pressure during induction of anesthesia in a simulated 
patient without autoregulation and a second dose of thiopental administered prior to 
intubations; A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy begins; and C) 
thiopental 4 mg/kg is injected. 
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Figure 11 Changes in cerebral blood flow during induction of anesthesia in a simulated 
patient without autoregulation and a second dose of thiopental administered prior to 
intubation; A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy begins; and C) 
thiopental, 4 mg/kg is injected. 
CHAPTER 5 
CONCLUSION 
The primary purpose of this work is to synthesize cerebrovascular physiology and 
pharmacology to allow analysis of complex effects of drugs and mechanical interventions 
on CBF and ICP occurring during the administration of anesthetics. The overall model 
was constructed from two constituent sub-models: a lumped parameter compartmental 
model of intracranial hemodynamics and a pharmacokinetic model of thiopental 
distribution. Interaction of the two sub-models was accomplished through concentration 
dependent resistance and MAP (mean arterial pressure). The model was tested by 
comparing simulation results to available experimental data. Although many aspects of 
the mathematical formulation and the values assigned to the variables are controversial, 
the important consideration is whether this overall approach is useful to examine the 
behavior of the cerebrovascular circulation in vivo. Some merits of our approach are: 
1. We analyzed the effect of autoregulation on intracranial hemodynamics; this can 
be extended to examine the effect of brain pathology on the cerebral circulation. 
For example, a brain tumor may be modeled by decreasing brain parenchyma 
compliance and/or increasing vascular resistance to CSF reabsorption. 
2. The model was used to study responses of the cerebrovascular system to 
thiopental and endotracheal intubation. There is no limitation on the variety or 
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combination of drugs which can be studied using this model. The relationship 
between plasma drug concentration and at least one cerebrovascular parameter 
must be available (or derived from the experimental data). 
3. We have examined hemodynamic responses of an intact and compromised 
cerebral circulation during the induction of general anesthesia; with appropriate 
modifications the model can be used to analyze other clinical situations. 
4. A drug administration regimen which prevents ICP increase associated with 
laryngoscopy and intubation was proposed using our model; this can be extended 
to develop optimum drug(s) therapy to achieve specific clinical goals. The model 
is also useful to conceptualize the problem and examine the interaction between 
various parts of the system. Areas that require further studies can be identified as 
well. 
Cerebrovascular System Model 
The appendix contains a listing of the VisSim® code for the Cerebrovascular System Model 
developed. 
Figure 12 Intracranial hemodynamic compound 
block with outputs 
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Figure 13 Intracranial hemodynamic compound 
block expanded 
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Figure 15 Pv cerebral venous pressure compound 
block expanded 
Figure 16 Pic intracranial pressure compound 
block expanded 
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Figure 17 Pvs venous sinus pressure compound 
block expanded 
Figure 18 Pc cerebral capillary pressure compound 
block expanded 
36 
Figure 19 Par arteriole pressure compound block 
expanded 
37 
Figure 20 Conductance equations compound 
block expanded 
38 
Figure 21 Gvs hydraulic conductance compound 
block expanded 
Figure 22 Compliance equations compound block 
expanded 
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Figure 23 Cai arteriolar compliance compound 
block expanded 
Figure 24 Cic intracranial compliance compound 
block expanded 
40 
Figure 25 Cvi intracranial venous compliance 
compound block expanded 




Figure 27q cerebral blood flow compound block 
expanded 
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